Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
A significant loss of muscle mass, often seen in users relying solely on GLP-1 therapy, can lead to metabolic slowdown, increased fatigue, functional weakness, and ultimately, weight regain once medication use is discontinued (Baggio & Drucker, 2021)
The medication's long half-life and gradual mechanism of action mean that a minor adjustment of 24 hours does not typically result in dangerous medication levels or sudden changes in blood glucose control
Energy Expenditure Research Unique to retatrutide among the GLP-1 family
For those with obesity or type 2 diabetes, this number jumps dramatically to over 50% 18
Doctors and researchers are approaching this topic with cautious optimism
Most patients begin with the Jumpstart option, which is a 4-month commitment
US$ 20.59
US$ 25.54
US$ 21.54
